Organix is a US-based Contract Research Organization (CRO) specializing in organic and medicinal chemistry. We provide highly specialized, outsourced chemistry services primarily to pharmaceutical, biotech, and government clients. Our core mission is to deliver elegant solutions to complex challenges, helping clients accelerate their projects from the discovery phase into the clinic.

Organix, as part of Symeres, is part of an integrated drug discovery and development company. This allows Organix to offer clients integrated solutions spanning from hit finding to clinical proof-of-concept. This integration ensures that almost every service can be handled internally, which offers clients confidence and convenience by safeguarding confidential project information within a single partner organization, also allowing seamless transfer of technology.

Yes. Since 2022, Organix has been part of Symeres, a European-based, integrated drug discovery and development company. This relationship allows Organix to leverage broader resources in pursuit of finding novel therapies, aligning with Symeres' brand essence: "Making Molecules Matter. Together."

Organix operates from a state-of-the-art facility in Woburn, MA, which is custom-built and specifically designed for specialized organic chemistry research.

Organix offers a comprehensive suite of chemistry-focused offerings, including:

● Custom Synthesis

● Specialized Synthesis (Lipids, Nucleotides, Polymers)

● Medicinal Chemistry

● Analytical Services

● Contract R&D

We are experts in complex chemistry and specialized synthesis, including:

● Complex Multi-Step Synthesis and Heterocyclic Chemistry.

● Carbohydrate Chemistry.

● Lipids and Nucleotides, including the synthesis of GMP-grade lipids for applications like mRNA delivery and siRNA delivery vehicles.

● GalNAc Chemistry for targeted drug delivery.

● Custom Polymer Synthesis with tailored properties, especially for drug delivery.

Our medicinal chemistry services include the proprietary synthesis of novel lipids, as well as the synthesis of standards from published literature. We provide crucial support for early-stage drug development, such as hit-to-lead studies and Structure-Activity Relationship (SAR) studies. Computational & medicinal chemists are available through Symeres, our parent organization.

We offer a full range of analytical testing and characterization services essential for quality control and compound characterization. Our techniques include NMR spectroscopy (including 2D-NMR), HPLC, LC-MS, GPC, and mass spectrometry.

Organix excels at solving complex synthetic problems, route scouting, and optimizing synthetic procedures for pharmaceutical and biotech clients, which accelerates their R&D pipelines.

In addition to our outsourced services, we sell a catalog of compounds directly via our website. These off-the-shelf products include compounds organized by class, such as:

● GalNAc and Lipids

● Arylisothiocyanates and Aryltributylstannanes

● Reference Standards, Drug Impurities, and Metabolites

● Monodispersed PEG

● Controlled Substances

Our primary differentiator is our US-based team of highly qualified scientists. Our collaborative, client-centric model emphasizes that clients are "buying the team rather than the service." We foster powerful collaborations and personal communication, embodying the message: "The lab next door, wherever you are."